- 11.3.2023
- Updates
Lucid News: An Ambitious Vision Drives Kentucky’s Ibogaine Plan to Treat Opioid Dependency
When Bryan Hubbard was appointed Executive Director of the newly formed Kentucky Opioid Abatement Advisory Commission in 2021, he had already been tracking psychedelic-assisted therapies in the media for three years.
Marijuana Moment: Veteran Access To Psychedelics Requires Balance Of Speed And Caution, Says Panel With VA And Former CDC Officials
Experts and advocates—including a Department of Veterans Affairs (VA) official and a former director of the Centers for Disease Control and Prevention (CDC)—recently convened for a Harvard University panel to discuss efforts to expand veteran access to psychedelic-assisted therapy.
Pharmacy Times: Psychedelic-Assisted Therapy Is Life-Changing for Veterans With PTSD, Yet Access to These Therapies Remain Outside the United States
Pharmacy Times interviewed Marcus Capone and Amber Capone, the co-founders of Veterans Exploring Treatment Solutions (VETS), on the current opportunities available for US veterans to seek psychedelic-assisted therapies for post-traumatic stress disorder (PTSD) and traumatic brain injuries (TBIs).
- 10.10.2023
- Updates
VETS Joins Coalition to Heal Invisible Wounds
Veterans, service members and their caregivers need better solutions for the invisible wounds of war.
Bloomberg: Toms Shoes Founder Talks Funding Plan For Psychedelics Movement
Blake Mycoskie, the founder of Toms Shoes, announced earlier this year that he’d give $100 million to support research into the medical and mental health potential of psychedelic drugs.